Stock Analysis·← Pickers

PRE

Prenetics Global Limited

Prenetics Global Limited (PRE) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 53.4, with 3/3 trend checks passing.

Price
$19.58
2026-07-16
Trend score
3/3
Uptrend
RSI (14)
53.4
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

PRE with MA50 and MA200

22.1518.4214.7010.977.2507/3110/2401/2204/1707/15
PRE2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$18.50+5.85% vs price
MA200
$17.17+14.02% vs price
RSI (14)
53.4Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
$14.00–$14.5525.7% below price · 3 touches
Support Quality
3 touches1.0× zone volume
Chart Summary
Trend summary for PRE

Prenetics Global Limited (PRE) is still trading in a constructive trend overall. The latest available price is $19.58, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 5.9% and above the 200-day moving average by 14.0%.

Momentum and stretch context

PRE currently has an RSI reading of 53.4, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing PRE next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About Prenetics Global Limited

As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Sheng Wu Yeung
Employees
98
Market cap
$332.9M
Beta
0.25
52-week range
$7.17 – $23.63
Dividend
No
Exchange
NASDAQ
Country
HK
IPO date
16 Jul 2021
ISIN
KYG722451229
CUSIP
G72245122
Company profile data from Financial Modeling Prep. PRE listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about PRE

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.